Skip to content

Individualized transfer strategy for polycystic ovary syndrome patients based on endometrial receptivity testing and non-invasive preimplantation potential assessment

Individualized transfer strategy for polycystic ovary syndrome patients based on endometrial receptivity testing and non-invasive preimplantation potential assessment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053824
Enrollment
Unknown
Registered
2021-11-30
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome (PCOS)

Interventions

Study Group 1:embryo transfer guided by ERA and EMBRACE
Study Group 2:embryo transfer guided by EMBRACE alone
Control Group:traditional embryo transfer

Sponsors

Sichuan Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 37 Years

Inclusion criteria

Inclusion criteria: 1. Women, aged 20-37 years; 2. BMI index 18-28kg/m^2; 3. Meet the diagnostic criteria for PCOS; 4. With IVF/ICSI indications, blastocyst culture, whole embryo freezing.

Exclusion criteria

Exclusion criteria: 1. Uterine lesions that may affect implantation (including history of intrauterine adhesions, endometrial polyps, endometritis, endometrial tuberculosis, endometrial hyperplasia, thin endometrium, submucosal fibroids, adenomyosis), uterine malformations; 2. Untreated severe hydrosalpinx with evidence of hydrosalpinx and uterine regurgitation; 3. Untreated serious medical and surgical diseases; 4. Patients planning PGT; 5. Any situation that other researchers consider unsuitable to participate in this study, such as mental factors, etc.

Design outcomes

Primary

MeasureTime frame
Intrauterine pregnancy rate;

Secondary

MeasureTime frame
Embryo implantation rate;Miscarriage rate;Ongoing clinical pregnancy rate;Live birth rate;Birth weight of newborn;Maternal/fetal complications;Biochemical pregnancy rate;

Countries

China

Contacts

Public ContactZeng Jiuzhi

Sichuan Maternal and Child Health Hospital

zengjiuzhi9@163.com+86 18908098215

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026